Capital Research Global Investors Allakos Inc. Transaction History

Capital Research Global Investors

$463 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $42 Million - $550 Million	-4,912,458 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $63.1 Million - $91 Million	-824,160 Reduced 14.37%	4,912,458 $520 Million
Q2 2021 Aug 16, 2021	SELL	$85.37 - $114.1 $52.2 Million - $69.7 Million	-610,912 Reduced 9.62%	5,736,618 $490 Million
Q1 2021 May 14, 2021	BUY	$109.73 - $153.66 $939,617 - $1.32 Million	8,563 Added 0.14%	6,347,530 $729 Million
Q4 2020 Feb 12, 2021	BUY	$79.58 - $152.45 $47.8 Million - $91.7 Million	601,281 Added 10.48%	6,338,967 $887 Million
Q3 2020 Nov 13, 2020	BUY	$66.43 - $90.99 $218,421 - $299,175	3,288 Added 0.06%	5,737,686 $467 Million
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $9.33 Million - $17.1 Million	211,940 Added 3.84%	5,734,398 $412 Million
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $6.03 Million - $12.7 Million	135,613 Added 2.52%	5,522,458 $246 Million
Q4 2019 Feb 18, 2020	BUY	$66.49 - $137.73 $21.8 Million - $45.1 Million	327,352 Added 6.47%	5,386,845 $514 Million
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $26.1 Million - $75.4 Million	840,705 Added 19.93%	5,059,493 $398 Million
Q2 2019 Aug 14, 2019	BUY	$36.0 - $44.73 $942,876 - $1.17 Million	26,191 Added 0.62%	4,218,788 $183 Million
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $23.9 Million - $36.7 Million	706,129 Added 20.25%	4,192,597 $170 Million
Q4 2018 Feb 14, 2019	BUY	$31.59 - $62.65 $2.54 Million - $5.03 Million	80,287 Added 2.36%	3,486,468 $175 Million
Q3 2018 Nov 14, 2018	BUY	$31.25 - $47.64 $106 Million - $162 Million	3,406,181 New	3,406,181 $144 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$17.9 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$6.64 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$5.4 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.8 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.32 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $91.5M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account